QAB


Also found in: Acronyms.

QAB

In Q, or basic telecommunication code, it means, “May I have clearance for … from [place and/or control] to [place and/or control] at … height above … datum?”
Mentioned in ?
References in periodicals archive ?
6 million pounds for the period mainly due to higher production of QAB 149, compared with 3.
SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) Announces Interim Financial Results for the Six Months Ended 30 June 2005
2 million pounds of revenue was recognised from GlaxoSmithKline on the phase III clinical trials of Requip(R) (ropinirole), AstraZeneca on the phase III clinical trials of budesonide HFA and Novartis on the first European approval of Foradil(R) Certihaler(R) and the phase II clinical trials of QAB 149.
SkyePharma Reports Preliminary Results Announcement for the Year Ended 31 December 2004
5 million pounds of revenue was recognised from GlaxoSmithKline on the phase III clinical trials of Requip(R) (ropinirole); AstraZeneca on the phase III clinical trials of Budesonide HFA and Novartis on the first European approval of Foradil(R) Certihaler(R) and the phase II clinical trials of QAB 149.
SkyePharma Interim Financial Results for the Six Months Ended 30 June 2004
SkyePharma has also entered into a second agreement with Novartis to jointly develop a dry-powder inhaler version of QAB 149, Novartis' novel long-acting bronchodilator.
SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R)
We have also recently signed a second agreement with Novartis to jointly develop a dry-powder inhaler version of QAB 149, Novartis' novel long-acting bronchodilator, and an agreement with GlaxoSmithKline to license our formulation technologies for application to the delivery of respiratory drugs, either by breath-actuated dry powder inhaler or by metered-dose aerosol inhaler.
SkyePharma and Vectura Form Strategic Alliance For Pulmonary Delivery Technologies

Encyclopedia browser ?
Full browser ?